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Abstract
Background: Women with severe pre-eclampsia/eclampsia are at risk of developing chronic hypertension in future.
Chronic hypertension may manifest initially as persistent hypertension at the end of the puerperium. The objective
was to determine the incidence and maternal biochemical, hematological and socio-demographic risk factors for
persistent hypertension in patients with pre-eclampsia/eclampsia.
Methods: This was a prospective cohort study conducted from November 2008 to May 2009 at Mulago hospital
labor ward and postnatal clinic. Participants were 200 women managed for pre-eclampsia/eclampsia and followed
up to the end of the puerperium. Data was collected through using pre-coded interviewer-administered
questionnaires, checking medical records and laboratory investigations. STATA (release 9) software was used for
data analysis. At bivariate analysis, the relative risk of persistent hypertension was estimated at the 95% confidence
level. Using multivariate logistic regression analysis, factors that were independently associated with persistent
hypertension were evaluated.
Results: Fifty four (27.7%) out of the total 195 women had persistent hypertension after puerperium. Serum
creatinine and the age of the patient were the only factors associated with persistence of hypertension after
puerperium.
Conclusion: Nearly every one in four mothers with pre-eclampsia/eclampsia are at risk of persistent hypertension
after the puerperium. Serum creatinine, serum uric acid and participants’ age were the only factors independently
associated with persistence of hypertension after the puerperium.
Background
Pre-eclampsia is an idiopathic multi-system disorder
specific to pregnancy. It is characterized by hypertension
(a blood pressure of higher of 140/90 mmHg or higher
in a previously normotensive women) and proteinuria.
Pre-eclampsia and eclampsia complicate about 6-8% all
pregnancies worldwide [1] and are associated with
increased maternal morbidity and mortality. They are
also associated with development of chronic hyperten-
sion [2] as well as cardiovascular and renal complica-
tions later in life. Women with pre-eclampsia/eclampsia
are at higher risk of obstetric complications like abrup-
tio placenta and intra-uterine growth restriction [2] as
compared to normotensive women. They also have a
higher risk of developing chronic hypertension in the
future (14.8% versus. 5.6%), and this risk increases mark-
edly on long-term follow up (to 51% versus 14%) [2].
Because they are at risk of developing chronic hyper-
tension, all women with pre-eclampsia/eclampsia require
follow up after delivery. Factors that predict chronic
hypertension include maternal age and gestation age of
onset of pre-eclampsia [3]. A higher maternal age [4]
and lower gestation age at onset increase risk of chronic
hypertension. During the postnatal period, the hyperten-
sion and proteinuria due to pre-eclampsia/eclampsia
resolve within six weeks, and women having persistent
hypertension and proteinuria thereafter may have an
underlying cause. Postnatal review at 6-12 weeks after
delivery provides an opportunity to ensure that manifes-
tations of pre-eclampsia and any associated systemic
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chronic hypertension among these women during fol-
low-up might prevent or reduce its long-term complica-
tions if relevant interventions to decrease or avert
associated renal or cardiovascular damage are instituted
in time. In Mulago hospital, about 3-4 patients with
pre-eclampsia are seen per day, constituting 8.2% of all
labour ward admissions. The objective of the study was
to evaluate the incidence and factors associated with
persistent hypertension in patients that present with
pre-eclampsia/eclampsia.
Methods
Being Uganda’s national referral hospital, Mulago
receives women booked with the hospital’s antenatal
clinic, self referrals and referrals from other health units.
The hospital conducts about 50-65 deliveries daily, over
25,000 deliveries per year. This was a prospective cohort
study carried out in new Mulago hospital’sl a b o rw a r d
and postnatal clinic, from 18
th November 2008 to 17
th
March 2009. Participants were women admitted in New
Mulago hospital with pre-eclampsia or eclampsia. These
were followed up to the end of the puerperium. Hyper-
tension in pregnancy was defined as any of the follow-
ing: i) a blood pressure measurement of higher than or
equal to 140 mmHg systolic or 90 mmHg diastolic
(measured at rest on at least 2 occasions in a patient of
more than 20 weeks of gestation); ii) a rise in systolic
pressure of 30 mmHg or higher and diastolic pressure
of 15 mmHg or higher, ((from the pre-pregnancy or
first trimester measurement, measured on at least 2
occasions 4 hours apart,). All women with essential
hypertension, chronic hypertension, hypertension in a
prior pregnancy, a history of hypertension in the first
trimester history, renal disease or pre- eclampsia in a
prior pregnancy were excluded from the analysis.
Pre-eclampsia was defined as presence of hypertension
(as defined above) and albuminuria (on urinary dipstick
examination). A diagnosis of mild pre-eclampsia was
made when a blood pressure of less than 160/110
mmHg was associated with proteinuria (albuminuria) of
2+ or less on urinary dipstick examination, at any time
during the management and subsequent follow up.
Severe pre-eclampsia was diagnosed as a blood pressure
of 160/110 mmHg or higher in association with protei-
nuria of 3+ or more on urinary dipstick examination, at
any time during the management and subsequent follow
up. A diagnosis of eclampsia was made when the patient
with features of pre-eclampsia developed convulsions
(tonic-clonic seizures). A diagnosis of HELLP syndrome
was made where the patient presented with hyperten-
sion, elevated hepatic lactate dehydrogenase enzymes
(greater than 600 units/liter), elevated aspartate and ala-
nine transaminase enzymes (above 50 international units
per liter) and platelet count less than 150,000 cells per
mm3. (All patients with HELLP syndrome had features
of severe pre-eclampsia. Presence of microangiopathic
hemolytic anemia was not evaluated). The diagnosis of
persistent hypertension was made when hypertension
(as defined above) was found at any time six weeks or
later postpartum.
Data collection
Data was collected through interviews using an inter-
viewer-administered questionnaire. Other data was col-
lected by participant examination, biomedical
investigations and review of participants’ medical
records. This data included social-demographic factors
(age, parity, marital status, spouse’s age,); obstetric fac-
tors (such as gestational age at presentation, gestation
age at disease onset, family history of hypertension or
pre-eclampsia and severity of pre-eclampsia. Biochemical
data included serial uric acid levels, creatinine levels,
platelet count, urinary protein levels and results of renal
function tests). Blood pressure was measured using the
manual sphygmomanometer machine in a sitting posi-
tion. Urine protein was determined by dipstick examina-
tion. The primary outcome was persistence of
hypertension at six weeks postpartum. The sample size
of 195 was estimated using the Kish and Leslie formula
(1965) where N = Z
2P(1-P)/D,
2 and assuming that the
incidence of chronic hypertension on a follow up of
women with pre-eclampsia/eclampsia is about 14.8% [2].
All participants received antihypertensive and magne-
sium sulphate therapy according to a standard protocol
as follows,: Magnesium sulphate 10 g intramuscularly
together with 4 g intravenously were used as loading
dose and 5 g intramuscularly every 4 hours until 24
hours later or as maintenance dose for all patients with
severe pre-eclampsia and eclampsia. All patients with
diastolic pressure above 100 mmHg received hydralla-
zine injection 5 mg every 30 minutes until the diastolic
was less than 100 mmHg. Antihypertensive treatment
was thereafter maintained with sublingual Nifedipine 20
mg. Continuous bladder drainage was instituted
throughout the patients’ hospital stay. The subsequent
care and mode of delivery followed standard obstetric
practice for pre-eclampsia/eclampsia.
Data analysis
At analysis, characteristics of participants with persistent
hypertension and those who were normotensive at six
weeks postpartum were compared. Baseline characteris-
tics of the participants were compared using Pearson’s
chi-square test for categorical data and Student t-test
for numerical data. To adjust for confounding and inter-
action, multivariate logistic-regression analysis was con-
ducted to determine factors that were independently
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sion, using STATA software. During modeling for
regression analyses, all variables of clinical importance
or with p-value 0.2 and less on bivariate analysis were
considered for inclusion. Persistent hypertension entered
as present = 1, absent = 0. Parity, number of living chil-
dren and age of spouse were entered as numerical vari-
ables. Participant age was evaluated as a numerical
variable and as 5-year age categories. The model good-
ness-of-fit of the final logistic regression models was
assessed by Pearson’s chi-square test.
Ethical Considerations
The study was approved by the research and ethics
committees of Makerere University Faculty of Medicine
and Mulago hospital. The participants gave written
informed consent to participate in the study, whereby
none were to be denied any healthcare in case they
declined to participate or withdrew from the study.
Medication and care for the pre-eclampsia/eclampsia
were provided free to all participants.
Results
During the study period, 200 participants with pre-
eclampsia/eclampsia were recruited into the study. We
analyzed data for 195 participants: two participants died
during follow up, while three failed to turn up for post-
partum review in the postnatal clinic. Of the partici-
pants, 25 (12.8%) had mild pre-eclampsia, 160 (82.1%)
had severe pre-eclampsia and 10 (5.1%) had eclampsia.
Only 150 patients (76.9%) had full evaluation for HELLP
syndrome, and of these, only 6 (3.1%) had HELLP syn-
drome. Out of 195 participants, 54 (27.7%) had persis-
tent hypertension and 141(72.3%) were found to have
normal blood pressure at six weeks postpartum.
Table 1 shows the socio-demographic characteristics
of the participants. Except for participants’ age, there
were no statistically significant differences in baseline
characteristics of participants (between those who had
persistent hypertension and those who were normoten-
sive at six weeks postpartum) (p-value > 0.05). Likewise,
the difference in family history of hypertension, family
history of diabetes, history of pre-eclampsia among sib-
lings and lifestyle factors (smoking and alcohol drinking)
was not statistically significant.
Table 2 compares the serum creatinine levels, seum
uric acid levels, platelet count and urine protein levels
at admission and after the puerperium among partici-
pants who had persistent hypertension and those who
had become normotensive. Serum uric acid: the mean
v a l u e so fs e r u mu r i ca c i da ta d m i s s i o nw e r e4 1 7 . 7( m g
per 100 mls) versus 365.1 as compared to 317.6 versus
275.3 after six weeks postpartum. Although, at admis-
sion, the uric acid levels were higher among those who
developed persistent hypertension, the difference
between the two groups was not statistically significant.
The difference in mean values of serum uric acid for
those normotensive and those with persistent hyperten-
sion was statistically significant at 6 weeks postpartum.
Platelet count: for the platelet count, the mean values
at both admission and six weeks postpartum were sig-
nificantly higher in the group that had persistent
hypertension.
Serum urea and creatinine: Though overall, the mean
serum urea and creatinine levels were higher at admis-
s i o na n de n do ft h ep u e r p e r i u mi nt h eg r o u pw i t hp e r -
sistent hypertension (as compared to the group who
became normotensive), only the difference in mean
levels at admission was statistically significant. Urine
protein levels: Though urine protein levels at admission
were comparable for the two groups (those who became
normotensive and those with persistent hypertension) at
recruitment, they were higher among those with persis-
tent hypertension. For example, there was 9.3% with
proteinuria of 3+ among those with persistent hyperten-
sion compared to 2.9% among those normotensive after
six weeks postpartum. Overall 44.4% of those with per-
sistent hypertension had some degree of proteinuria,
implying a strong association between postpartum pro-
teinuria and persistent hypertension six weeks
postpartum.
Table 3 shows the independent factors associated with
persistence of hypertension. Participant age (especially
among those in the category of 30-34 years) was statisti-
cally significant in predicting persistent hypertension.
S e r u mc r e a t i n i n ea ta d m i s s i o na n du r i n ep r o t e i na ts i x
weeks postpartum were significantly associated with per-
sistent hypertension.
Discussion
The study assessed the incidence of persistent hyperten-
sion and factors associated with persistent hypertension
in patients with pre-eclampsia/eclampsia. The study
shows that the incidence of persistent hypertension is
27.7% (54/195). Participants’ age (especially among
women aged 30-34 years), serum creatinine at admis-
sion, serum uric acid six weeks postpartum and urine
protein at six weeks postpartum were the factors inde-
pendently associated with persistent hypertension.
Family history of hypertension, history of diabetes and
history of pre-eclampsia among siblings were not signifi-
cantly associated with persistent hypertension.
The finding of higher mean serum uric acid levels and
higher serum creatinine levels as well as urine protein in
the women with persistent hypertension might result
from renal dysfunction in pre-eclampsia. During normal
pregnancy, the increased blood volume leads to marked
reduction in serum uric acid and creatinine levels. Renal
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edly increased. In pre-eclampsia, renal perfusion and
glomerular filtration are markedly reduced secondary to
renal dysfunction. While the definite cause of renal dys-
function in pre-eclampsia remains unclear, one possible
mechanism might be damage caused by endothelin, a
potent endogenous vasoconstrictor peptide produced by
endothelial cells [5]. Consequently, plasma uric acid
levels are elevated in proportion to severity of pre-
eclampsia. The renal insult secondary to vasospasm
might be one of several potential factors involved in the
pathogenesis of chronic hypertension among these
women with pre-eclampsia. Likewise, chronic
hypertension and pre-eclampsia may have similar or
related risk factors. In women in whom endothelin
levels are persistently elevated, serum uric acid is
increased and creatinine clearance is diminished [5]. Ele-
vated serum uric acid levels, which are prognostic for
severe pre-eclampsia and eclampsia, are indicators of
disease severity and remote prognosis for women at risk
of renal and cardiovascular complications.
In this cohort study, there are several limitations. The
blood pressure measurements beyond 6 weeks postpar-
tum were only available for about half of the patients as
many did not return for review beyond the six weeks.
Data is not available on blood pressure at 12 weeks
Table 1 Comparison of baseline characteristics of participants with and without persistent hypertension
Characteristics Normal Blood Pressure at 6 weeks postpartum Persistent hypertension 6 weeks postpartum P-value
n = 141 n = 54
n (%) n (%)
Age in complete years
15-19 36 (25.5) 3 (5.6)
20-24 49 (34.6) 18 (33.3) 0.001
25-29 35 (24.8) 12 (22.2)
30-34 16 (11.3) 13 (24.1)
35-39 3 (2.1) 7 (12.6)
40 years and above 2 (1.4) 1 (1.9)
Education
No formal education 4 (2.9) 1 (1.2)
Primary 60 (42.9) 21 (39.6)
Secondary 58 (41.4) 29 (54.7) 0.187
Tertiary 18 (12.9) 2 (3.8)
Occupation
Peasant/house wife 92 (65.2) 35 (64.8)
Business woman 35 (24.8) 15 (27.8) 0.325
Unemployed 14 (9.9) 4 (7.4)
Marital status
Single 30 (21.3) 8 (14.8)
Married 111 (78.7) 46 (85.2) 0.640
Family history of Hypertension
Yes 65 (46.1) 32 (59.3)
No 76 53.9) 22 (40.7) 0.230
History of Diabetes
Yes 20 (14.2) 11 (20.4)
No 121 (85.8 43 (79.6) 0.570
History of pre-eclampsia among sisters
Yes 26 (17.3) 10 (19.2) 0.752
No 115 (82.7) 42 (80.8)
History of smoking
Yes 4 (2.8) 2 (1.9) 0.714
No 137 (97.2) 52 (98.1)
History of alcohol
Yes 42 (29.8) 18 (33.3) 0.574
No 99 (72.2) 36 (66.6)
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drome as liver enzymes were not assessed routinely for
all patients either at initiation of the cohort or during
subsequent follow-up. Resolution of hypertension in
pregnancy may occur beyond 6 weeks postpartum.
Therefore, assessment at 6 weeks (or before 12 weeks
postpartum) may over-estimate the incidence of persis-
tent hypertension. We acknowledge this limitation as a
possible explanation for the high incidence of persistent
hypertension in this cohort. The incidence of persistent
hypertension is rather high compared to that of Sibai et
al. [2]. This difference could be attributable to the short
Table 2 Comparison of laboratory results (mean values) at admission and after 6 weeks for the two groups
Variables Periods Normal BP Mean plus standard
deviation
Abnormal BP (Persistent Hypertension) Mean plus
standard deviation
P-value
† Serum uric acid (μmol/l) 365.1 ± 330.1 417.7 ± 200 0.27
At admission 275.3 ± 200.6 317.6 ± 101.9 0.002
After 6 weeks
† Mean Platelet level (×10
9/liter) 202.4 ± 79.6 228.9 ± 96 0.051
At admission 241.9 ± 59.2 268.1 ± 79 0.014
After 6 weeks
† Serum Creatinine (mg/100 ml) 948 ± 67.5 0.004
At admission 72.6 ± 38.4 251.7 ± 1289 0.071
After 6 weeks 55.8 ± 21.3
† Serum Urea (mg/100 ml) 10.7 ± 24.3 0.066
At admission 5.5 ± 14.3 8.6 ± 17.9 0.361
After 6 weeks 6.5.0 ± 12.5
*Urine protein at admission
+ 1.0 (0.7) 0.0 (0.0) 0.165
++ 60 (42.6) 22 (40.7)
+++ 57 (40.4) 16 (29.6)
++++ 23 (16.3) 16 (29.6)
*Urine protein after 6 weeks postpartum
Negative 104 (74.3) 26 (48.2) 0.000
Trace 22 (15.7) 4 (7.4)
+ 8 (5.7) 16 (29.6)
++ 2 (1.4) 3 (3.6)
+++ 4 (2.9) 5 (9.3)
Key: *Figures indicate numbers and percentages of participants in both groups
†Figures indicate mean values and the standard deviation
Units for serum creatinine and urea are mg per 100 mls, while those for platelet count are (× 10
9 per liter.
Table 3 Predictors of persistent hypertension after 6 weeks
Predictors Risk ratio Confidence interval (CL) P-value
Age 2.61 1.31 - 8.40 0.027
15-19 2.43 0.75 - 7.87 0.138
20 -24 4.16 1.30 - 13.33 0.017
25 - 29 7.23 2.29 - 22.85 0.001
30 - 34 2.99 0.41 - 21.77 0.278
35 - 39 1.49 0.84 - 2.63 0.172
40-44
Smoking 1.79 0.48 - 6.67 0.382
Family history of hypertension 0.87 0.55 - 1.38 0.555
History of alcohol 0.92 0.58 - 1.47 0.701
History of pre-eclampsia 1.06 0.67 - 1.67 0.717
Serum creatinine at admission 2.04 1.35 - 3.09 0.001
Serum urea 0.90 0.57 -1.44 0.672
Urine protein at admission 1.64 0.99 -2.70 0.051
Serum uric acid at end of puerperium 2.70 1.30 - 6.67 0.035
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pared to Sibai’s study of 7 years. While endothelial
damage is the most likely factor in the pathogenesis of
pre-eclampsia, many factors associated with pre-eclamp-
sia as well as their mechanisms are not well understood.
Women who develop chronic hypertension following
pre-eclampsia/eclampsia are often unaware of their pro-
blem and future risk. In a study to determine the blood
pressure and renal function seven years after pre-
eclampsia/eclampsia complicated pregnancy [6], only 10
out of 28 women with chronic hypertension knew they
were hypertensive. Microalbuminuria in such women is
common, is closely related to residual renal dysfunction
and is an early marker of glomerular disease [6,7].
Women who develop recurrent second trimester severe
pre-eclampsia or eclampsia are more likely to have an
underlying renal disease and tend to have a high risk of
developing chronic hypertension on follow up. In a
study to establish the likelihood of an underlying renal
disease or chronic hypertension among women with a
history of pre-eclampsia, 10% developed chronic hyper-
tension and 2% had an underlying renal disease [8]. This
highlights the importance of follow up for all women
managed for pre- eclampsia/eclampsia who have high
serum uric acid and creatinine levels after puerperium.
This enables identification of women with underlying
renal disease or ongoing renal damage, both of which
impact negatively on subsequent health and pregnancy
outcome.
The finding that serum creatinine was a predictor for
persistent hypertension implies that we could use base-
line serum creatinine levels when the patients are
admitted to predict women who are at risk of develop-
ing chronic hypertension in future. Whereas some stu-
dies doubt the prognostic value of uric acid for maternal
and fetal outcome in hypertensive pregnancy [9,10],
hyperuricemia was associated with shorter gestations,
lower birth weight, increased risk of preterm birth and
risk of small-for-gestational-age infants, whether protei-
nuria was present or not [11]. This suggests that uric
acid may be an important prognostic factor as effective
as proteinuria at identifying gestational hypertensive
pregnancies at increased risk [11].
Elevated uric acid levels in pre-eclamptic women may
not simply be a marker of disease severity but possibly
contribute directly to the pathogenesis of the disorder
through ability of uric acid to promote inflammation,
oxidative stress and endothelial dysfunction [12].
Increased adenosine may be a source of this uric acid
[13]. Its levels are an indicator of ongoing oxidative stress
[14] and could be responsible for the vascular injury of
pre-eclampsia [15]. Though often considered an antioxi-
dant, biochemical and in-vitro data indicate that non-
crystalline, soluble uric acid can react to form radicals,
increase lipid oxidation and induce various pro-oxidant
effects in vascular cells [16]. From in-vitro and in- vivo
studies, uric acid may contribute to endothelial dysfunc-
tion through inducing anti-proliferative effects on
endothelium and impairing nitric oxide production in
vascular smooth muscle cells (VSMCs) [16]. Hyperten-
sion develops through increased chemokine and cytokine
expression, induction of the renin-angiotensin system
and increased vascular C-reactive protein (CRP) expres-
sion [16]. This injury recovers within one month postpar-
tum [17]. Improvement in glomerular filtration capacity
is accompanied by recovery of hypertension to near-nor-
mal levels and significant improvement in albuminuria.
Conclusion
Nearly one of every four mothers with pre-eclampsia/
eclampsia are at risk of persistent hypertension at the
end of the puerperium. Maternal age, serum creatinine
and serum uric acid levels are predictors of persistent
hypertension after the puerperium in women with pre-
eclampsia and eclampsia.
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